.
MergerLinks Header Logo

New Deal


Announced

Completed

Juno Pharmaceuticals completed the acquisition of Omega Laboratories.

Synopsis

Juno Pharmaceuticals, a biopharmaceutical company, completed the acquisition of Omega Laboratories, a domestic specialty injectable pharmaceutical manufacturer. Financial terms were not disclosed. “We are proud of this acquisition that solidifies Juno’s ability to improve drug supply with medications that are critically needed to support our healthcare system. We are Canadian owned and operated and will continue to support our domestic market while expanding into new geographies with dependable and high-quality Canadian-made pharmaceuticals,” Mark Mantel, Juno CEO.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US